Elan Résultats passés
Passé contrôle des critères 5/6
Elan has been growing earnings at an average annual rate of 19.4%, while the Healthcare industry saw earnings growing at 6.9% annually. Revenues have been growing at an average rate of 15.8% per year. Elan's return on equity is 22.7%, and it has net margins of 5.8%.
Informations clés
19.4%
Taux de croissance des bénéfices
19.5%
Taux de croissance du BPA
Healthcare Croissance de l'industrie | 7.9% |
Taux de croissance des recettes | 15.8% |
Rendement des fonds propres | 22.7% |
Marge nette | 5.8% |
Dernière mise à jour des bénéfices | 30 Jun 2024 |
Mises à jour récentes des performances passées
Ventilation des recettes et des dépenses
Comment Elan gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
30 Jun 24 | 44,489 | 2,591 | 6,617 | 0 |
31 Mar 24 | 43,055 | 2,550 | 6,450 | 0 |
31 Dec 23 | 41,426 | 2,519 | 6,086 | 0 |
30 Sep 23 | 39,925 | 2,207 | 5,986 | 0 |
30 Jun 23 | 38,441 | 2,158 | 5,804 | 0 |
31 Mar 23 | 37,329 | 2,151 | 5,676 | 0 |
31 Dec 22 | 36,265 | 2,083 | 5,636 | 0 |
30 Sep 22 | 35,121 | 2,186 | 5,544 | 0 |
30 Jun 22 | 34,021 | 2,126 | 5,414 | 0 |
31 Mar 22 | 32,904 | 2,024 | 5,259 | 0 |
31 Dec 21 | 31,635 | 1,905 | 5,078 | 0 |
30 Sep 21 | 30,481 | 1,886 | 4,895 | 0 |
30 Jun 21 | 29,112 | 1,738 | 4,771 | 0 |
31 Mar 21 | 27,592 | 1,613 | 4,603 | 0 |
31 Dec 20 | 26,056 | 1,446 | 4,495 | 0 |
30 Sep 20 | 24,611 | 1,276 | 4,294 | 0 |
30 Jun 20 | 23,340 | 1,132 | 4,191 | 0 |
31 Mar 20 | 22,410 | 1,038 | 4,110 | 0 |
31 Dec 19 | 21,518 | 989 | 3,980 | 0 |
30 Sep 19 | 20,642 | 960 | 3,870 | 0 |
30 Jun 19 | 19,930 | 952 | 3,758 | 0 |
31 Mar 19 | 19,174 | 929 | 3,625 | 0 |
31 Dec 18 | 18,585 | 865 | 3,548 | 0 |
30 Sep 18 | 17,939 | 861 | 3,387 | 0 |
30 Jun 18 | 17,296 | 772 | 3,343 | 0 |
31 Mar 18 | 16,673 | 694 | 3,307 | 0 |
31 Dec 17 | 15,466 | 657 | 3,084 | 0 |
Des revenus de qualité: 6099 has a high level of non-cash earnings.
Augmentation de la marge bénéficiaire: 6099's current net profit margins (5.8%) are higher than last year (5.6%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 6099's earnings have grown by 19.4% per year over the past 5 years.
Accélération de la croissance: 6099's earnings growth over the past year (20.1%) exceeds its 5-year average (19.4% per year).
Bénéfices par rapport au secteur d'activité: 6099 earnings growth over the past year (20.1%) exceeded the Healthcare industry 9.6%.
Rendement des fonds propres
ROE élevé: 6099's Return on Equity (22.7%) is considered high.